Visual deficits and cognitive assessment of multiple sclerosis: confounder, correlate, or both?

J Neurol

Department of Neurology, Buffalo Neuroimaging Analysis Center (BNAC), Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, State University of New York, 100 High Street, Buffalo, NY, 14203, USA.

Published: July 2021

AI Article Synopsis

  • The study investigated how visual impairment relates to cognitive performance in patients with multiple sclerosis (MS) compared to healthy controls (HCs).
  • It involved 141 MS patients and 50 HCs who underwent cognitive and visual tests, including optical coherence tomography (OCT) assessments to analyze retinal health.
  • Results showed that specific visual measures (like low-contrast letter acuity and OCT-derived metrics) significantly correlated with cognitive test performance, indicating that visual health is important for cognitive functioning in MS patients.

Article Abstract

Background: The relationship between visual impairment and cognitive performance in multiple sclerosis (MS) remains poorly understood.

Objective: To determine associations between visual acuity and optical coherence tomography (OCT) measures with cognitive performance of MS patients and healthy controls (HCs).

Methods: 141 MS patients (with and without MS optic neuritis; MSON) and 50 HCs underwent neuropsychological, visual, and OCT testing. California Verbal Learning Test (CVLT-II), Brief Visuospatial Memory Test (BVMT-R), and Symbol Digit Modalities Test (SDMT) were used. Patients with test performance below - 1.5 standard deviations of the mean HCs scores were labeled as cognitive impairment. Visual ability was assessed with 100%, 2.5%, and 1.25% low-contrast letter acuity (LCLA) charts. OCT-derived peripapillary retinal nerve fiber layer (pRNFL) thickness, macular volume (MV), macular ganglion cell inner plexiform (mGCIP) thickness (as a sum of GC and IP layers), and macular inner nuclear layer (mINL) were computed.

Results: 100% and 2.5% LCLA associated with SDMT in MS and HCs (p < 0.001; and p < 0.012, respectively). In MSON patients, visually demanding tests were explained by pRNFL and macular volume for SDMT (β = 0.172, p = 0.039 and β = 0.27, p = 0.001) and MV for BVMT-R (β = 0.21, p = 0.012). In non-MSON, only mINL was predictor of CVLT-II. pRNFL and MV predicted cognitive impairment with an accuracy of 72.2% (Negelkerke R = 0.234). These findings were driven by associations within the progressive MS subgroup. HC's SDMT performance was explained by mGCIP (β = 0.316, p = 0.001).

Conclusions: Both LCLA and OCT-based measures (pRNFL and macular volume) were associated with MS cognitive performance. OCT-based measures were also significant predictors of cognitive status in MS patients. mGCIP associated with cognitive performance in HCs.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00415-021-10437-5DOI Listing

Publication Analysis

Top Keywords

multiple sclerosis
8
cognitive performance
8
100% 25%
8
visual
5
visual deficits
4
cognitive
4
deficits cognitive
4
cognitive assessment
4
assessment multiple
4
sclerosis confounder
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!